Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
60,893,283
-
Total 13F shares
-
12,724,210
-
Share change
-
+262,822
-
Total reported value
-
$28,246,000
-
Put/Call ratio
-
73%
-
Price per share
-
$2.22
-
Number of holders
-
27
-
Value change
-
+$582,554
-
Number of buys
-
10
-
Number of sells
-
1
Institutional Holders of Equillium, Inc. - Common Stock (EQ) as of Q3 2022
As of 30 Sep 2022 Equillium, Inc. - Common Stock (EQ) had 27 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 12,724,210 shares of stock of the company.
Largest 10 holders included Decheng Capital Management III (Cayman), LLC, VICTORY CAPITAL MANAGEMENT INC, FRANKLIN RESOURCES INC, VANGUARD GROUP INC, Samsara BioCapital, LLC, TANG CAPITAL MANAGEMENT LLC, Cota Capital Management, LLC, DEUTSCHE BANK AG\, DCF Advisers, LLC, and GEODE CAPITAL MANAGEMENT, LLC.
This table shows 27 institutional shareholders of the security as of 30 Sep 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.